BRKR
Bruker Corporation
NASDAQ · USHealthcareMedical - Devices
$56.17-3.54%
Price as of Jul 20, 2026
BRKR capital
Bruker Corporation capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 0.68x
- Net debt / equity
- 0.63x
- Debt / assets
- 0.27x
- Debt / EBITDA
- 5.52x
- Net debt / EBITDA
- 5.08x
Liquidity & coverage
- Current ratio
- 1.55x
- Quick ratio
- 0.72x
- Cash ratio
- 0.10x
- Interest coverage
- 3.43x
- EBITDA / interest
- 5.10x
- Working capital
- $748.5M
Cash & dividend
- FCF / debt
- 0.03x
- Cash flow / debt
- 0.08x
- Dividend per share
- $0.20
- Dividend yield
- 0.4%
- Dividend growth 1y
- +0.0%
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.